Artezio as well as experts from JP Morgan, Johnson & Johnson, and representatives of healthcare companies from all over the globe will discuss the current market development situation during the crisis caused by the coronavirus pandemic.
Today the global market is undergoing major upheavals due to Covid-19. The introduction of the quarantine measures made numerous companies, including healthcare and pharmaceutical, reconsider their market development strategies. Remote interaction technologies became a lifeline for businesses. At times when people have to stay as far away from each other as possible, remote interaction technologies allow keeping the same level of healthcare services and help people get access to medicine and other products.
The organizers of BioNJ’s 10th Annual BioPartnering believe that the time has come for active support and promotion of initiatives aimed at saving people’s lives.
“We need to minimize the obstacles to healthcare development. Technology innovations help push healthcare forward, make discoveries, and create conditions for quality treating of people even under hard conditions of the world pandemic,” say the creators of BioNJ’s 10th Annual BioPartnering.
Artezio’s participation in BioNJ’s 10th Annual BioPartnering is not accidental. The company is an expert in the field of platform development for telemedicine in the USA. Artezio’s developers understand not only technological aspects of building virtual clinics but also have deep legislative expertise in this area.
At BioNJ’s 10th Annual BioPartnering, Artezio’s representatives will hold a number of meetings with partners who aim at developing remote healthcare services in the USA and require experienced developers. Healthcare software solutions developed by Artezio are already used successfully in the US. Evaluating the interest of current players on the US market, Artezio is confident in expanding its involvement in enhancing telemedicine in the USA.